title: RANTES in exhaled breath condensate of stable and unstable asthma patients.
abstract: RANTES has been implicated in the allergic inflammation of asthma by promoting the migration and activation of the inflammatory cells, including eosinophils. The study was undertaken to evaluate RANTES levels in the exhaled breath condensate (EBC) of asthmatics with different degrees of asthma severity. EBC was collected from 33 patients with allergic asthma (11 with steroid-naïve mild asthma, 10 with ICS-treated, stable mild-to-moderate asthma, 12 with ICS-treated unstable, severe asthma) and seven healthy volunteers. In the three groups of asthmatics, RANTES concentrations in EBC were significantly higher compared with healthy volunteers. RANTES levels were significantly higher in patients with unstable asthma than in the two groups with stable disease. We observed statistically significant correlations between the concentrations of RANTES in EBC and F(ENO) in the three studied groups of asthmatics; notably, the correlation between the parameters described above was strong positive in the group of unstable and steroid-naïve stable asthmatics. We also discovered a significantly positive correlation between RANTES in EBC and the serum ECP or blood eosinophil count in the groups of asthmatics with severe, unstable asthma and between RANTES and serum ECP in the group of steroid-naïve stable asthmatics. Measurements of RANTES in EBC may provide another useful diagnostic tool for detecting and monitoring inflammation in patients with asthma.
authors.affiliation: Department of Allergology and Internal Medicine, Medical University of Bialystok, Poland. z.zietkowski@wp.pl
authors.forename: Z
authors.initials: Z
authors.lastname: Zietkowski
authors.forename: M M
authors.initials: MM
authors.lastname: Tomasiak
authors.forename: R
authors.initials: R
authors.lastname: Skiepko
authors.forename: A
authors.initials: A
authors.lastname: Bodzenta-Lukaszyk
mesh_terms: D000328:Adult; D001249:Asthma / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D015415:Biomarkers / Q000032:analysis; D001944:Breath Tests / Q000379:methods; D018946:Chemokine CCL5 / Q000032:analysis*; D047150:Eosinophil Cationic Protein / Q000097:blood; D004804:Eosinophils / Q000473:pathology; D005260:Female; D005541:Forced Expiratory Volume; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D007958:Leukocyte Count; D008297:Male; D055815:Young Adult
chemical_list: D015415:Biomarkers; D018946:Chemokine CCL5; D005938:Glucocorticoids; D007073:Immunoglobulin E; D047150:Eosinophil Cationic Protein